Status:
COMPLETED
Comparison of Remifentanil With Dexmedetomidine or Midazolam in Regards of Sedation Effectivity and Postoperative Cognitive Functions in Cystoscopies
Lead Sponsor:
Gazi University
Conditions:
Postoperative Cognitive Functions
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
The aim of the study was to compare the effects of remifentanil-dexmedetomidine and remifentanil-midazolam with mini-mental state examination (MMSE) in monitored anesthesia care (MAC) patients undergo...
Detailed Description
Forty patients undergoing cystoscopy receiving remifentanil infusion of 0.05 microgram per kg-1 min-1 were randomized into two groups: Either dexmedetomidine 1 microgram per kg -1 (GroupD) or midazola...
Eligibility Criteria
Inclusion
- patients with indication of cystoscopy must be able to have sedation
Exclusion
- hypersensitivity to drugs used
- morbid obesity
- coronary disease
- diabetes mellitus and other endocrinologic diseases
- pregnancy
- psychomotor diseases
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01491009
Start Date
May 1 2006
End Date
November 1 2010
Last Update
December 13 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gazi University Faculty of Medicine Hospital
Ankara, Turkey (Türkiye), 06100